D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHK
1351
DELISTED
Chesapeake Energy Corporation
CHK
| $4.96M | 0.01% |
5,765
-4,334
| -43% | -$3.72M |
|
|
ZEN
1352
DELISTED
ZENDESK INC
ZEN
| $4.95M | 0.01% |
169,952
-1,251
| -0.7% | -$35.1K |
|
1353
TripAdvisor
TRIP
$1.64B
| $4.92M | 0.01% |
121,376
-682,479
| -85% | -$27.7M |
|
1354
CALL
Dollar Tree
DLTR
$24.1B
| $4.91M | 0.01% |
56,600
+16,600
| +42% | +$1.27M |
|
1355
Haemonetics
HAE
$3.66B
| $4.91M | 0.01% |
109,438
+18,186
| +20% | +$756K |
|
1356
PUT
Synchrony
SYF
$24.3B
| $4.89M | 0.01% |
157,400
| – | – |
|
1357
CALL
Kimberly-Clark
KMB
$36.9B
| $4.88M | 0.01% |
41,500
| – | – |
|
1358
Olin
OLN
$2.54B
| $4.86M | 0.01% |
+141,809
| New | +$4.42M |
|
1359
PUT
IPG Photonics
IPGP
$3.77B
| $4.85M | 0.01% |
+26,200
| New | +$4.35M |
|
|
MLNX
1360
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $4.85M | 0.01% |
102,847
-9,800
| -9% | -$445K |
|
1361
PUT
Churchill Downs
CHDN
$6.17B
| $4.85M | 0.01% |
141,000
+120,000
| +571% | +$3.84M |
|
1362
CALL
DuPont de Nemours
DD
$18.7B
| $4.85M | 0.01% |
27,642
-10,267
| -27% | -$1.71M |
|
1363
PUT
Teleflex
TFX
$5.91B
| $4.84M | 0.01% |
+20,000
| New | +$4.35M |
|
1364
PUT
Weibo
WB
$1.93B
| $4.83M | 0.01% |
48,840
+25,600
| +110% | +$2.26M |
|
1365
PUT
Stanley Black & Decker
SWK
$14.4B
| $4.83M | 0.01% |
+32,000
| New | +$4.6M |
|
1366
ICF International
ICFI
$1.45B
| $4.83M | 0.01% |
89,452
-11,966
| -12% | -$566K |
|
|
WCG
1367
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.83M | 0.01% |
28,100
| – | – |
|
1368
National Grid
NGG
$82.8B
| $4.8M | 0.01% |
86,593
+31,637
| +58% | +$1.77M |
|
1369
CALL
Halliburton
HAL
$27.7B
| $4.8M | 0.01% |
104,300
-31,200
| -23% | -$1.31M |
|
1370
W.P. Carey
WPC
$17.1B
| $4.79M | 0.01% |
72,608
+25,082
| +53% | +$1.67M |
|
|
NXGN
1371
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.79M | 0.01% |
304,572
-48,485
| -14% | -$783K |
|
|
PPLI
1372
CALL
People Inc
PPLI
$3.1B
| $4.77M | 0.01% |
227,174
+144,922
| +176% | +$2.81M |
|
1373
Casey's General Stores
CASY
$31.7B
| $4.76M | 0.01% |
43,509
+2,488
| +6% | +$265K |
|
1374
PUT
Abercrombie & Fitch
ANF
$4.34B
| $4.75M | 0.01% |
329,300
| – | – |
|
1375
RenaissanceRe
RNR
$13.7B
| $4.75M | 0.01% |
35,147
-11,994
| -25% | -$1.69M |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.